NCT03476889 (VOYAGE) is a NA clinical trial of Infant formula in Growth, sponsored by Nutricia Research.

Who is sponsoring NCT03476889?

NCT03476889 is sponsored by Nutricia Research.

What drugs are being tested in NCT03476889?

Interventions in NCT03476889: Infant formula.

Is NCT03476889 still recruiting?

NCT03476889 is currently status unknown. Last updated 10 September 2018.

Last reviewed 2018-09-10 · How we verify

NCT03476889: VOYAGE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Tolerance of a Partly Fermented Infant Formula With Prebiotic Oligosaccharides in Healthy Infants

Status unknown NA Last updated 10 September 2018

What this trial tests

NA trial testing Infant formula in Growth in 252 participants. Status unknown.

Timeline

19 July 2018

Primary endpoint
1 March 2021

1 March 2021

Quick facts

Lead sponsor	Nutricia Research
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	252
Start date	19 July 2018
Primary completion	1 March 2021
Estimated completion	1 March 2021
Sites	1 location across Poland

Drugs / interventions tested

Infant formula — full drug profile →

Conditions studied

Growth — all drugs for Growth →

Sponsor

Nutricia Research — full company profile →

Who can join

Adults 1 Day to 14 Days, any sex, with Growth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised, controlled, double-blind, parallel group, multi-country study to investigate the safety and tolerance of a partly fermented infant formula containing prebiotic oligosaccharides in healthy term infants.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.
Vandenplas Y, de Halleux V, Arciszewska M, Lach P, et al · · 2020 · cited 33× · PMID 33233658 · DOI 10.3390/nu12113560
Human Milk Oligosaccharides: Decoding Their Structural Variability, Health Benefits, and the Evolution of Infant Nutrition.
Duman H, Bechelany M, Karav S. · · 2024 · cited 18× · PMID 39796552 · DOI 10.3390/nu17010118

Verify or expand the search:

Other trials of Infant formula

Trials testing the same drug.

NCT04795076 — Effect of Feeding With Nutrient Dense Formula in Malnourished Infants and Children With Congenital Heart Defects · NA · completed
NCT04182425 — Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis · completed
NCT03487094 — Growth and Tolerance of Infants Fed Formula for 16 Weeks · NA · completed
NCT03320837 — Metabolomic Profile of Urine Samples From Neonates Fed With Breast Milk and an Infant Formula Enriched With Synbiotics · completed
NCT03513991 — Evaluation of Different Protein Content of Formulas on Nutrition Status of Infants. · NA · completed

Other recruiting trials for Growth

Currently open trials in the same condition.

NCT06018636 — Impact of Diet and Nutrition on Growth and Development in Young Children · recruiting

Other Nutricia Research trials

Trials by the same sponsor.

NCT07243743 — Assessment of the Glycemic Responses to Nutritional Products-INQ-2526 · NA · completed
NCT06797349 — Glin4: Assessment of the Glycemic Responses to Nutritional Products · Phase 4 · completed
NCT06920550 — A Growth Artificial Intelligence Algorithm for leNgth and Weight Study · recruiting
NCT06628024 — Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk. · NA · completed
NCT05731206 — Hypoallergenicity of a Hydrolyzed Protein Infant Formula · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03476889 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nutricia Research
Last refreshed: 10 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03476889.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing